Evidence map›Paper›PMID 16931806›Full record

ArticleAmerican journal of respiratory cell and molecular biology2007

The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival.

Yijie Wang, Mandy M Zeigler, Gregory K Lam, Melissa G Hunter, Tim D Eubank, Valery V Khramtsov, Susheela Tridandapani, Chandan K Sen, Clay B Marsh

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Article
  3. Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. AKT Isoforms in Macrophage Activation, Polarization, and Survival.Current topics in microbiology and immunology · 2022
    Article
  9. Review
  10. Article
  11. Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yijie WangDorothy M Davis Heart and Lung Research Institute, Department of Internal Medicine, Ohio State University Medical Center, Columbus, OH 43210, USA.
Mandy M Zeigler
Gregory K Lam
Melissa G Hunter
Tim D Eubank
Valery V Khramtsov
Susheela Tridandapani
Chandan K Sen
Clay B Marsh
The Ohio State University Wexner Medical Center · US

Funding

NF-kappaB:an Akt target &regulator of monocyte survivalR01HL067176 · NHLBI · OHIO STATE UNIVERSITY · PI MARSH, CLAY B · 2001 to 2011
$3.2M
Redox Control of Wound HealingR01GM069589 · NIGMS · OHIO STATE UNIVERSITY · PI SEN, CHANDAN K · 2004 to 2013
$2.3M
INTRACELLULAR PATHWAYS REGULATING MONOCYTE SURVIVALR01HL063800 · NHLBI · OHIO STATE UNIVERSITY · PI MARSH, CLAY B · 2000 to 2004
$1.4M
A NEW PARADIGM FOR FIBROSIS: MONOCYTE ACTIVATION OF TGFR01HL066108 · NHLBI · OHIO STATE UNIVERSITY · PI MARSH, CLAY B · 2001 to 2004
$1.2M
NHLBI NIH HHS HL63800NHLBI NIH HHS HL66108NHLBI NIH HHS HL67176NIGMS NIH HHS GM69589
6 · The paper itself

Abstract

M-CSF induces PI 3-kinase activation, resulting in reactive oxygen species (ROS) production. Previously, we reported that ROS mediate macrophage colony-stimulating factor (M-CSF)-induced extracellular regulated kinase (Erk) activation and monocyte survival. In this work, we hypothesized that M-CSF-stimulated ROS products modulated Akt1 and p38 activation. Furthermore, we sought to clarify the source of these ROS and the role of ROS and Akt in monocyte/macrophage survival. Macrophages from p47(phox-/-) mice, lacking a key component of the NADPH oxidase complex required for ROS generation, had reduced cell survival and Akt1 and p38 mitogen-activated protein kinase (MAPK) phosphorylation compared with wild-type macrophages in response to M-CSF stimulation, but had no difference in M-CSF-stimulated Erk. To understand how ROS affected monocyte survival and signaling, we observed that NAC and DPI decreased cell survival and Akt1 and p38 MAPK phosphorylation. Using bone marrow-derived macrophages from mice expressing constitutively activated Akt1 (Myr-Akt1) or transfecting Myr-Akt1 constructs into human peripheral monocytes, we concluded that Akt is a positive regulator of monocyte survival. Moreover, the p38 MAPK inhibitor, SB203580, inhibited p38 activity and M-CSF-induced monocyte survival. These findings demonstrate that ROS generated from the NADPH oxidase complex contribute to monocyte/macrophage survival induced by M-CSF via regulation of Akt and p38 MAPK.

Indexed as

AnimalsBone Marrow CellsCells, CulturedCell SurvivalEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHumansImidazolesMacrophage Colony-Stimulating FactorMacrophagesMiceMonocytesNADPH Oxidasesp38 Mitogen-Activated Protein KinasesPhosphorylationProto-Oncogene Proteins c-aktAKT1 protein, humanExtracellular Signal-Regulated MAP KinasesImidazolesMacrophage Colony-Stimulating FactorNADPH Oxidasesp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktPyridinesReactive Oxygen SpeciesSB 203580

Identifiers

PMID16931806
PMCPMC1899309
OpenAlexW2119231799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.